Aggressive non-Hodgkin lymphoma (NHL) treatment in 296 Oncology clinics in Europe
296 clinics specializing in Oncology providing treatment of Aggressive non-Hodgkin lymphoma (NHL) Aggressive non-Hodgkin lymphoma (NHL) is a fast-growing cancer that affects the lymphatic system. It can cause enlarged lymph nodes, fever, night sweats, weight loss, and may require intensive chemotherapy, radiation therapy, or stem cell transplant for treatment. disease in Europe.
Albania · 1
Austria · 24
Belarus · 3
Belgium · 6
Bulgaria · 3
Croatia · 1
Czech Republic · 21
Denmark · 3
Finland · 1
France · 25
Germany · 36
Greece · 3
Hungary · 11
Ireland · 6
Italy · 12
Latvia · 3
Luxembourg · 1
Moldova · 1
Netherlands · 9
Norway · 3
Poland · 4
Portugal · 15
Romania · 4
Russia · 24
Serbia · 1
Slovakia · 20
Spain · 12
Sweden · 1
Switzerland · 14
Ukraine · 1
United Kingdom · 26
You can select a specific country
Albania · 1
Austria · 24
Belarus · 3
Belgium · 6
Bosnia and Herzegovina · 1
Bulgaria · 3
Croatia · 1
Czech Republic · 21
Denmark · 3
Finland · 1
France · 25
Germany · 36
Greece · 3
Hungary · 11
Ireland · 6
Italy · 12
Latvia · 3
Luxembourg · 1
Moldova · 1
Netherlands · 9
Norway · 3
Poland · 4
Portugal · 15
Romania · 4
Russia · 24
Serbia · 1
Slovakia · 20
Spain · 12
Sweden · 1
Switzerland · 14
Ukraine · 1
United Kingdom · 26
Sorted by:
Relevance
Rating
Relevance
Clinics grouping by rating
Clinic with the highest rating of 5 — Berkana clinic in Moscow, Russia and 2 more, clinic with the most reviews number of 2235 — Hôpital Paris Saint-Joseph in Paris, France.
With rating 4.0 and over — 77 clinics .
Countries with the highest number of clinics treating the diseases:
Aggressive non-Hodgkin lymphoma (NHL):
worldwide
742 clinics
Brazil
48 clinics
India
45 clinics
Germany
36 clinics
Mexico
32 clinics
Australia
28 clinics
Related procedures:
Procedures are likely to be used for Aggressive non-Hodgkin lymphoma (NHL) treatment:
Allogeneic bone marrow transplantation (BMT),
Autologous bone marrow transplantation (BMT),
Chemotherapy for lymphoma,
Chimeric antigen receptor (CAR) T-cell therapy,
and
Cord blood stem cell transplantation
.